Advertising VUGA Media Group |  Gossip Stone TV   |  Lifestyle Magazine  |  Coolaser Clinic
Germfree Launches New Equipment Line for Sterile Product Preparation

Germfree Launches New Equipment Line for Sterile Product Preparation

Germfree Launches New Equipment Line for Sterile Product Preparation
Biosafety Cabinet

Germfree’s new Class II, Type A2 Biosafety Cabinet

LAS VEGAS – December 2, 2022 – (Newswire.com)

Germfree, a Florida based company, is introducing its new line of aseptic PEC (primary engineering control) equipment at the ASHP Midyear Clinical Meeting in Las Vegas. The newly redesigned equipment includes Laminar Flow Hoods, Biological Safety Cabinets, and Cleanroom Pass-Through Boxes.  These new products build on Germfree’s 60 years of aseptic PEC expertise in both the hospital compounding and pharmaceutical industries. The equipment has been designed to meet and exceed the strict cGMP and USP / regulatory requirements found in these industries.  

“The USP and standards have changed the working environment for many in the compounding industry,” said Ryan Henry, Marketing and Product Segment Manager at Germfree. “We listened to our customers and responded with new designs that are ideally suited for cleanroom use, enhancing the cleanability, durability, and ergonomics that they have come to expect from our products.”

All of the new products are constructed from stainless steel, both in the work areas and on the exterior of the units. The new biosafety cabinet line features an automatic, adjustable, tempered glass sliding sash and touch screen controls that come pre-loaded with instructional videos on proper usage and care for the equipment. The laminar flow line includes touch controls and low glare LED lights integrated into the work area. Both units have a night mode setting that allows the hood to remain running during periods of non-use while reducing energy consumption.

The cleanroom pass-through boxes utilize mechanical interlocks to only allow one door to be open at a time. The active HEPA purge cycle is triggered by closing either door while the interlocks remain locked until the cycle is complete. These units have been designed with an upward door swing that reduces the equipment footprint and allows for universal installation.

“Providing aseptic environments to the hospital compounding and pharmaceutical industries has been incredibly important to Germfree going back to our founding in 1962,” said Kevin Kyle, CEO of Germfree. “We are proud to be able to continue to serve these vital industries and innovate products that prevent sterile product contamination and protect patient safety.”

About Germfree: Germfree Laboratories LLC creates environments that serve life science innovation and advance global health. The company, founded in 1962, designs, engineers and manufactures equipment and facilities to serve the compounding pharmacy, biopharmaceutical and biocontainment industries throughout the world. 

Contact Information:

Ryan Henry

Marketing and Product Segment Manager

rhenry@germfree.com

386.265.4300

Press Release Service
by
Newswire.com

Original Source:

Germfree Launches New Equipment Line for Sterile Product Preparation

UPDATE: Cornerstone Specialty Network Hosts a Successful Community Oncology Focused Data Review Meeting: October 2022

UPDATE: Cornerstone Specialty Network Hosts a Successful Community Oncology Focused Data Review Meeting: October 2022Cornerstone Specialty Network Cornerstone Specialty Network
NEW HOPE, Pa. – December 1, 2022 – (Newswire.com)

Patient Demand for Medicinal Cannabis in Australia Continues to Grow

Patient Demand for Medicinal Cannabis in Australia Continues to GrowLast year, the number of Australians taking medicinal cannabis surpassed 100,000. As access to the treatment gets easier, patient demand continues to skyrocket.

HealthJoy Announces Partnership With Consociate Health

HealthJoy Announces Partnership With Consociate HealthThe partnership will help Consociate deliver simplified healthcare navigation to members

CHICAGO – Decem…

UPDATE: Cornerstone Specialty Network Hosts a Successful Community Oncology Focused Data Review Meeting: October 2022

UPDATE: Cornerstone Specialty Network Hosts a Successful Community Oncology Focused Data Review Meeting: October 2022Cornerstone Specialty Network, LLC Cornerstone Specialty Network, LLC
NEW HOPE, Pa. – December 1, 2022 – (Newswire…

Thynk Health and Riverian Partner to Fight Lung Cancer With Advanced AI and Deep Learning Technologies

Thynk Health and Riverian Partner to Fight Lung Cancer With Advanced AI and Deep Learning TechnologiesThynk Health & Riverain
LEXINGTON, Ky. – December 1, 2022 – (Newswire.com)

Home Health Lab Startup Bisu Collaborates With Polaris Dawn to Develop New Ways to Monitor Astronaut Health

Home Health Lab Startup Bisu Collaborates With Polaris Dawn to Develop New Ways to Monitor Astronaut HealthBisu’s “lab-on-a-chip” urine and saliva analyzer is intended for both consumer and astronaut use.

TOKYO – December 1, 2022 – (Newswire.com)

Traveling in space leads to bone loss, muscle loss, and an increased risk of kidney stone formation, often starting within the first 24 hours of spaceflight as calcium levels in bone and tissue decrease and are expelled in urine. A new research experiment, selected for inclusion in the upcoming Polaris Dawn spaceflight mission, aims to show if monitoring the first urine sample in the morning could provide a simple way to track astronaut health in space. If successful, the research will provide a pathway to use compact, new inflight monitoring techniques. The day’s first urine sample typically has the highest urine calcium levels in the day and taking measurements from this sample might offer a workable way to assess in-flight bone loss and kidney stone risk. As both space accessibility and long-duration human spaceflights increase, keeping crews healthy by providing personalized, targeted countermeasures will be essential. This will require small, easy-to-use, low-power devices that can provide actionable information using easily obtainable samples of urine or saliva, such as a first-morning void.

Bisu is a startup that helps people improve their health and fitness through lab-grade testing at home. Working with former astronaut Jay Buckey, MD, Professor of Medicine and Director of the Space Medicine Innovations Lab at the Geisel School of Medicine at Dartmouth, Bisu will support the post-flight analysis of first-morning void urine samples gathered from the Polaris Dawn crew to assess the effect of spaceflight on markers of bone loss, muscle loss, and kidney stone risk. If successful, this research could pave the way for inflight monitoring with new technologies, such as the microfluidic urine and saliva analyzer Bisu has developed. Because weightlessness affects people differently, this kind of in-flight monitoring could provide targeted countermeasures.

“People will be spending longer times in space, and they may not be able to do the extensive countermeasure programs currently used on the space station,” says Prof. Jay Buckey. “We need simple ways to monitor people while they are in space so that the countermeasure program can be targeted to each person’s individual needs. This research puts us on the path toward that.”

“We’re delighted to be working with Polaris Dawn and Prof. Buckey on this pioneering research,” says Daniel Maggs, co-founder & CEO at Bisu. “This research reflects Bisu’s commitment to advancing human health by making valuable health data accessible to all – whether on Earth or in space.”

About Polaris Dawn

Polaris Dawn is the first of the Polaris Program’s three human spaceflight missions. SpaceX is targeting no earlier than March 2023 for Falcon 9’s launch of Dragon and the Polaris Dawn crew from Launch Complex 39A at NASA’s Kennedy Space Center in Florida. Polaris Dawn endeavors to reach the highest Earth orbit ever flown, attempt the first-ever commercial spacewalk, conduct extensive research to further our understanding of human health on Earth and during future long-duration spaceflights, and test Starlink’s laser-based communications in space. For more information, visit polarisprogram.com/dawn.

About Bisu

Bisu is a healthtech startup that provides personalized, preventative advice at home, through nutrition and hormone tests using microfluidic “lab-on-a-chip” technology. In late 2021, Bisu announced a $3.2m seed round and collaboration with ASICS, took home the Good Design Award in the wellness category, and won the US Sports & Fitness Industry Association’s startup challenge.

Bisu’s flagship product, Bisu Body Coach, is currently in beta and can be applied for at www.bisu.com.

About the Space Medicine Innovations Laboratory at the Geisel School of Medicine at Dartmouth

The Space Medicine Innovations Laboratory is devoted to solving biomedical problems presented by long-duration space flight. The lab has performed work on bone loss, decompression sickness, motion sickness, and psychological countermeasures for isolation and confinement. The lab also advances work that began with NASA into other areas of research. 

Please address all press inquiries to press@bisu.com.

Contact Information:

Daniel Maggs

press@bisu.com



Press Release Service
by
Newswire.com

Original Source:

Home Health Lab Startup Bisu Collaborates With Polaris Dawn to Develop New Ways to Monitor Astronaut Health

Zeto Implements encevis’ Seizure Detection and Trending Algorithms

Zeto Implements encevis’ Seizure Detection and Trending AlgorithmsThe only zero-prep, full-montage, rapid EEG solution for clinical use now offers near real-time notification of ongoing seizures by using reliable FDA cleared seizure detection software

Zeto Implements encevis’ Seizure Detection and Trending Algorithms
Zeto-encevis PR

Zeto Implements encevis’ Seizure Detection and Trending Algorithms

SANTA CLARA, Calif. – December 1, 2022 – (Newswire.com)

Zeto, Inc., an innovative EEG brain monitoring company, announced today the integration of FDA cleared seizure detection and trending algorithms developed by encevis, now available as part of the Zeto EEG platform. encevis is powered by the AIT Austrian Institute of Technology, a renowned research and technology organization in Europe, and their EEG analysis software is widely utilized and peer reviewed by physicians across the world.

These new tools will help Zeto’s customers speed up EEG reviews. The trending module graphically reports several hours of EEG into a simple display to allow rapid assessment of brain states. The seizure detection component offers high sensitivity with low false alarm rates, matching and in parts surpassing industry benchmarks. Proven by three independent clinical publications, and harvesting the power of AI and deep learning, the software provides a detailed overview of seizures and suspicious EEG activity.

“According to current studies, 18% of critically ill patients with serious brain diseases suffer from unrecognized non-convulsive epileptic seizures, frequently leading to neurological disabilities. The joint efforts of Zeto and encevis will make EEG faster to read by automatically detecting and orienting the reader to abnormalities. Seizures will be automatically detected and marked in the EEG for review. Near real-time detection notifies medical staff about patients with ongoing clinical seizures,” said Dr. Tilmann Kluge, head of Medical Signal Analysis of AIT.

“We are excited to integrate encevis’ seizure detection and trending tools into our platform. Collaborative projects such as this ensure a seamless user experience and enable healthcare providers to offer the best care to their patients at an affordable price,” said Florian Strelzyk, Chief Sales Officer at Zeto.

Zeto EEG analysis features will continue to evolve as more third party integrations become available. Zeto is committed to driving innovation in brain monitoring by opening its platform to strategic projects and partnerships that empower health care providers to diagnose their patients rapidly and more effectively.

About Zeto

Zeto, Inc. is an award-winning, privately held medical technology company located in Santa Clara, California, that is focused on transforming the way electroencephalography (EEG) is performed at hospitals and clinics. Zeto’s revolutionary FDA-cleared EEG headset and cloud platform bring the traditional EEG procedure to the 21st century. 

To learn more about Zeto’s products, including the remote EEG monitoring, please visit: https://zeto-inc.com or email us at info@zetoinc.com.

About encevis

encevis is a part of the AIT Austrian Institute of Technology, Austria’s largest non-university research institute, is among the European research institutes a specialist in the key infrastructure issues of the future.

Learn more: https://www.encevis.com

Contact Information:

Irina Nazarova

Marketing Manager

irina.nazarova@zetoinc.com

9174351226

Press Release Service
by
Newswire.com

Original Source:

Zeto Implements encevis’ Seizure Detection and Trending Algorithms

Kelly Mahler, OTD, OTR/L, Releases New Big Book of Interoception Games

Kelly Mahler, OTD, OTR/L, Releases New Big Book of Interoception GamesThe Big Book of Interoception Games
LANCASTER, Pa. – December 1, 2022 – (Newswire.com)

Rising Obesity Rates; NextMed to the Rescue

Rising Obesity Rates; NextMed to the RescueNextMed NextMed Weight Loss Program
NEW YORK – December 1, 2022 – (Newswire.com)

Advertising VUGA Media Group |  Gossip Stone TV   |  Lifestyle Magazine  |  Coolaser Clinic Business Newspaper |   Miami News   |   Lifestyle Magazine  |   Fashion Magazine | Digital Newspaper Lifestyle Magazine | Woman Magazine Lifestyle News Politic News |   Miami News   |   Lifestyle Magazine |   Politics News   |   Lifestyle Magazine